查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1417480

HPV檢測和子宮頸抹片檢查市場報告：至2030年的趨勢、預測和競爭分析

HPV Testing and Pap Test Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

HPV 檢測和子宮頸抹片檢查的趨勢和預測

到2030年，全球 HPV 檢測和子宮頸抹片檢查市場預計將達到 75 億美元，2024年至2030年年複合成長率為 6.5%。該市場的主要促進因素是HPV病例數量的增加以及由此導致的子宮頸癌的增加、人們對子宮頸癌篩檢工作的認知不斷提高以及子宮頸癌研究和開發計劃的資金籌措增加。全球 HPV 檢測和子宮頸抹片檢查市場的未來充滿希望，醫院/診所和實驗室市場也充滿機會。

HPV 檢測與子宮頸抹片檢查市場洞察

Lucintel 預測，由於市場參與企業的投資增加以及與陰道癌相比子宮頸癌的發生率較高，子宮頸癌篩檢在預測期內仍將是很大的區隔。

在預測期內，北美仍將是最大的地區，因為對子宮頸癌早期檢測的高度認知、既定的篩檢建議以及有利的醫療保健償付環境推動了擴張。

常問問題

Q1.市場規模有多大？

A1.到2030年，全球 HPV 和子宮頸抹片檢查市場預計將達到 75 億美元。

Q2.市場成長預測如何？

A2.預計2024年至2030年，全球 HPV 檢測和子宮頸抹片檢查市場將以 6.5%的年複合成長率成長。

Q3.影響市場成長的主要促進因素有哪些？

A3.該市場的主要驅動力是 HPV 病例和相關子宮頸癌數量的增加、人們對子宮頸癌篩檢措施的認知不斷提高以及子宮頸癌研究和開發計劃的資金籌措增加。

Q4.市場的主要細分市場是什麼？

A4.全球HPV 檢測和子宮頸抹片檢查市場的未來前景看好，醫院/診所和實驗室市場也充滿機會。

Q5.市場上主要企業有哪些？

A5.HPV檢測和子宮頸抹片檢查的主要企業如下。

  • Abbott
  • QIAGEN
  • BD
  • Quest Diagnostics
  • Hologic
  • F. Hoffmann-La Roche
  • Femasys
  • Arbor Vita
  • NURX
  • Seegene

Q6.未來最大的細分市場是什麼？

A6.Lucintel預計，由於市場參與企業對該行業的投資增加以及子宮頸癌的發生率高於陰道癌，子宮頸癌篩檢在預測期內將繼續增加，預測將繼續是很大的細分市場。

Q7.未來五年預計哪個地區將成為最大的市場？

A7.在預測期內，北美將繼續成為最大的地區，因為對子宮頸癌早期檢測的高度認知、既定的篩檢建議以及有利的醫療保健償付環境推動了擴張。

Q8.可以客製化報告嗎？

A8.是的，Lucintel 提供 10%的客製化服務，無需額外付費。

目錄

第1章 執行摘要

第2章 全球 HPV 檢測和子宮頸抹片檢查檢測市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球HPV檢測和子宮頸抹片檢查市場趨勢（2018-2023）和預測（2024-2030）
  • 按測試類型分類的全球 HPV 檢測和子宮頸抹片檢查測試市場
    • 子宮頸抹片檢查
    • HPV檢測
  • 依產品分類的全球 HPV 檢測和子宮頸抹片檢查測試市場
    • 裝置
    • 消耗品
    • 服務
  • 全球 HPV 檢測和子宮頸抹片檢查測試市場（依應用）
    • 子宮頸癌篩檢
    • 陰道癌篩檢
  • 依最終用途分類的全球 HPV 檢測和子宮頸抹片檢查測試市場
    • 醫院和診所
    • 實驗室
    • 其他

第4章 2018-2030年區域市場趨勢及預測分析

  • 全球 HPV 檢測和子宮頸抹片檢查檢查市場（依地區）
  • 北美 HPV 檢測和子宮頸抹片檢查市場
  • 歐洲HPV檢測及子宮頸抹片檢查檢測市場
  • 亞太地區 HPV 檢測和子宮頸抹片檢查檢查市場
  • 其他地區HPV檢測及子宮頸抹片檢查檢測市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球 HPV 檢測和子宮頸抹片檢查檢測市場成長機會（按檢測類型）
    • 全球 HPV 檢測和子宮頸抹片檢查試驗市場成長機會（依產品）
    • 全球 HPV 檢測和子宮頸抹片檢查試驗市場成長機會（依應用）
    • 全球 HPV 檢測和子宮頸抹片檢查試驗市場成長機會（以最終用途）
    • 全球 HPV 檢測和子宮頸抹片檢查試驗市場成長機會（依地區）
  • 全球 HPV 檢測和子宮頸抹片檢查檢測市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 全球HPV檢測與子宮頸抹片檢查檢測市場容量擴張
    • 全球 HPV 檢測和子宮頸抹片檢查市場的合併、收購和合資企業
    • 認證和許可

第7章 主要企業概況

  • Abbott
  • QIAGEN
  • BD
  • Quest Diagnostics
  • Hologic
  • F. Hoffmann-La Roche
  • Femasys
  • Arbor Vita
  • NURX
  • Seegene
簡介目錄

HPV Testing and Pap Test Trends and Forecast

The future of the global HPV Testing and Pap Test market looks promising with opportunities in the hospitals & clinics and laboratories market. The global HPV Testing and Pap Test market is expected to reach an estimated $7.5 billion by 2030 with a CAGR of 6.5% from 2024 to 2030. The major drivers for this market are growing HPV cases and the ensuing rise in cervical cancer, increasing awareness of initiatives for screening for cervical cancer, and rising financing for cervical cancer research and development projects.

A more than 150-page report is developed to help in your business decisions.

HPV Testing and Pap Test by Segment

The study includes a forecast for the global HPV Testing and Pap Test by test type, product, application, end use, and region.

HPV Testing and Pap Test Market by Test Type [Shipment Analysis by Value from 2018 to 2030]:

  • Pap Test
  • HPV Test

HPV Testing and Pap Test Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Instruments
  • Consumables
  • Services

HPV Testing and Pap Test Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Cervical Cancer Screening
  • Vaginal Cancer Screening

HPV Testing and Pap Test Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals & Clinics
  • Laboratories
  • Others

HPV Testing and Pap Test Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of HPV Testing and Pap Test Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies HPV Testing and Pap Test companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the HPV Testing and Pap Test companies profiled in this report include-

  • Abbott
  • QIAGEN
  • BD
  • Quest Diagnostics
  • Hologic
  • F. Hoffmann-La Roche
  • Femasys
  • Arbor Vita
  • NURX
  • Seegene

HPV Testing and Pap Test Market Insights

Lucintel forecasts that cervical cancer screening will remain the larger segment over the forecast period due to growing market participants' investments in the industry, and greater occurrences of cervical cancer compared to vaginal cancer.

North America will remain the largest region over the forecast period due to high awareness of cervical cancer early detection, well-established screening recommendations, and a good healthcare reimbursement environment are driving expansion.

Features of the Global HPV Testing and Pap Test Market

Market Size Estimates: HPV testing and pap test market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: HPV testing and pap test market size by various segments, such as by test type, product, application, end use, and region in terms of value ($B).

Regional Analysis: HPV testing and pap test market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different test type, product, application, end use, and regions for the HPV Testing and Pap Test market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the HPV Testing and Pap Test market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the HPV Testing and Pap Test market size?

Answer: The global HPV Testing and Pap Test market is expected to reach an estimated $7.5 billion by 2030.

Q2. What is the growth forecast for HPV Testing and Pap Test market?

Answer: The global HPV Testing and Pap Test market is expected to grow with a CAGR of 6.5% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the HPV Testing and Pap Test market?

Answer: The major drivers for this market are growing HPV cases and the ensuing rise in cervical cancer, increasing awareness of initiatives for screening for cervical cancer, and rising financing for cervical cancer research and development projects.

Q4. What are the major segments for HPV Testing and Pap Test market?

Answer: The future of the global HPV Testing and Pap Test market looks promising with opportunities in the hospitals & clinics and laboratories market.

Q5. Who are the key HPV Testing and Pap Test market companies?

Answer: Some of the key HPV Testing and Pap Test companies are as follows.

  • Abbott
  • QIAGEN
  • BD
  • Quest Diagnostics
  • Hologic
  • F. Hoffmann-La Roche
  • Femasys
  • Arbor Vita
  • NURX
  • Seegene

Q6. Which HPV Testing and Pap Test market segment will be the largest in future?

Answer: Lucintel forecasts that cervical cancer screening will remain the larger segment over the forecast period due to growing market participants' investments in the industry, and greater occurrences of cervical cancer compared to vaginal cancer.

Q7. In HPV Testing and Pap Test market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to high awareness of cervical cancer early detection, well-established screening recommendations, and a good healthcare reimbursement environment are driving expansion.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the HPV Testing and Pap Test market by test type (pap test and HPV test), product (instruments, consumables, and services), application (cervical cancer screening and vaginal cancer screening), end use (hospitals & clinics, laboratories, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global HPV Testing and Pap Test Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global HPV Testing and Pap Test Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global HPV Testing and Pap Test Market by Test Type
    • 3.3.1: Pap Test
    • 3.3.2: HPV Test
  • 3.4: Global HPV Testing and Pap Test Market by Product
    • 3.4.1: Instruments
    • 3.4.2: Consumables
    • 3.4.3: Services
  • 3.5: Global HPV Testing and Pap Test Market by Application
    • 3.5.1: Cervical Cancer Screening
    • 3.5.2: Vaginal Cancer Screening
  • 3.6: Global HPV Testing and Pap Test Market by End Use
    • 3.6.1: Hospitals & Clinics
    • 3.6.2: Laboratories
    • 3.6.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global HPV Testing and Pap Test Market by Region
  • 4.2: North American HPV Testing and Pap Test Market
    • 4.2.1: North American HPV Testing and Pap Test Market by Application: Cervical Cancer Screening and Vaginal Cancer Screening
    • 4.2.2: North American HPV Testing and Pap Test Market by End Use: Hospitals & Clinics, Laboratories, and Others
  • 4.3: European HPV Testing and Pap Test Market
    • 4.3.1: European HPV Testing and Pap Test Market by Application: Cervical Cancer Screening and Vaginal Cancer Screening
    • 4.3.2: European HPV Testing and Pap Test Market by End Use: Hospitals & Clinics, Laboratories, and Others
  • 4.4: APAC HPV Testing and Pap Test Market
    • 4.4.1: APAC HPV Testing and Pap Test Market by Application: Cervical Cancer Screening and Vaginal Cancer Screening
    • 4.4.2: APAC HPV Testing and Pap Test Market by End Use: Hospitals & Clinics, Laboratories, and Others
  • 4.5: ROW HPV Testing and Pap Test Market
    • 4.5.1: ROW HPV Testing and Pap Test Market by Application: Cervical Cancer Screening and Vaginal Cancer Screening
    • 4.5.2: ROW HPV Testing and Pap Test Market by End Use: Hospitals & Clinics, Laboratories, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global HPV Testing and Pap Test Market by Test Type
    • 6.1.2: Growth Opportunities for the Global HPV Testing and Pap Test Market by Product
    • 6.1.3: Growth Opportunities for the Global HPV Testing and Pap Test Market by Application
    • 6.1.4: Growth Opportunities for the Global HPV Testing and Pap Test Market by End Use
    • 6.1.5: Growth Opportunities for the Global HPV Testing and Pap Test Market by Region
  • 6.2: Emerging Trends in the Global HPV Testing and Pap Test Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global HPV Testing and Pap Test Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global HPV Testing and Pap Test Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Abbott
  • 7.2: QIAGEN
  • 7.3: BD
  • 7.4: Quest Diagnostics
  • 7.5: Hologic
  • 7.6: F. Hoffmann-La Roche
  • 7.7: Femasys
  • 7.8: Arbor Vita
  • 7.9: NURX
  • 7.10: Seegene